Derivative exercise or conversion — not an open-market buy.
Traded Mar 5, 2026 · Filed Mar 5, 2026
A board member of Docusign sold $17K of Docusign shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$16,818
Shares × reported transaction price
91 days after results of Dec 4, 2025, 12 days before results of Mar 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.4% | −1.5% | −1.9% |
| 30 days | −1.3% | −2.0% | +0.7% |
| 90 days | +4.6% | +12.6% | −8.0% |
| 180 days | +34.3% | +13.8% | +20.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of Docusign sold $144K of Docusign shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.